IKBKB-DT: A Potential Drug Target for Various Diseases (G101929897)

Target Name: IKBKB-DT

NCBI ID: G101929897

IKBKB-DT

Other Name(s): ALAL-1 | IKBKB divergent transcript

IKBKB-DT: A Potential Drug Target for Various Diseases

IKBKB-DT (ALAL-1) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a key regulator of the immune response and has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Recent studies have identified IKBKB-DT as a potential drug target for the treatment of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and location in the body make it an attractive target for drug development, as it is difficult to target with small molecules.

IKBKB-DT has been shown to play a role in the regulation of cellular processes that are important for the development and progression of cancer. It has been shown to promote the growth and survival of cancer cells, and to inhibit the death of cancer cells that have been exposed to chemotherapy.

In addition to its role in cancer, IKBKB-DT has also been implicated in the development and progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. It has been shown to contribute to the build-up of toxic protein aggregates in the brain that are thought to play a role in the development of these diseases.

IKBKB-DT has also been shown to be involved in the regulation of the immune system, which is important for the development and progression of autoimmune disorders. It has been shown to suppress the activity of T cells, which are a key part of the immune system, and to promote the activity of regulatory T cells, which help to control the immune response.

In conclusion, IKBKB-DT is a protein that has the potential to be a drug target for the treatment of a variety of diseases. Its unique structure and location in the body make it an attractive target for drug development, as it is difficult to target with small molecules. Further research is needed to fully understand the role of IKBKB-DT in the development and progression of various diseases, and to identify the most effective way to use it as a therapeutic.

Protein Name: IKBKB Divergent Transcript

The "IKBKB-DT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IKBKB-DT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets